February 2018 – Page 11

Rani makes it rain with $53m

Rani Therapeutics has now raised $142m in total, its latest investors including GV, Ping An Ventures, GeneScience, AstraZeneca, Shire and Novartis.

Cardlytics carts in $70m from IPO

The purchase data analytics platform, which is backed by Aimia and Fidelity Information Services, had raised almost $210m in venture financing.

Huami hauls in $110m in IPO

The Xiaomi-affiliated smart wearable device maker has become the latest Chinese company to go public in the US, floating in the middle of its range.

AcFun accelerates to its end

Video sharing platform AcFun, which had raised at least $110m from backers including Youku Tudou and SoftBank, has shut down its operations.

Lendingkart carries series C to $87m

Corporate venturing units Sistema Asia Fund and Bertelsmann India Investments took part in the round’s $10.5m first close in September last year.

Analysis: Ping An Ventures to raise $1.3bn

Ping An Ventures is raising a total of $1.3bn for two life sciences-focused fund: $500m for a dollar-denominated fund and $800m for a renminbi-denominated one.

Corporate venturing deal net: 5-9 February 2018

Arrive, the investment and startup services unit formed by music management firm Roc Nation, provided an undisclosed amount of funding for Robinhood, the US-based creator of a fee-free online brokerage, on Tuesday. Robinhood had previously raised $176m from investors including GV, a subsidiary of internet technology group Alphabet, DST Global, Greenoaks Capital, Index Ventures, Andreessen… Continue reading Corporate venturing deal net: 5-9 February 2018

Subtree to grow with $10m seed round

Big data storage systems provider DDN led the data management technology developer’s seed round.

Corporates help pump $10m into Clarke

US-based industrial valve manufacturer Clarke Industrial Engineering has closed a $10m series B round co-led by subsidiaries of oil and gas suppliers Saudi Aramco and Chevron. Saudi Aramco Energy Ventures (SAEV) and Chevron Technology Ventures invested alongside angel syndicate New World Angels. The funding follows a $3.1m series A round led by New World Angels… Continue reading Corporates help pump $10m into Clarke

Syndesi sends for corporates in $21m series A

Belgium-based drug developer Syndesi Therapeutics has raised €17m ($20.8m) in a series A round co-led by Novo Seeds, a corporate venturing unit owned by pharmaceutical firm Novo. Venture capital firm Fountain Healthcare Partners co-led the round, which included healthcare group Johnson & Johnson’s corporate venturing arm, Johnson & Johnson Innovation – JJDC, and V-Bio Ventures,… Continue reading Syndesi sends for corporates in $21m series A

Month: February 2018